KININS, SIGNALING AND ASTHMA
KININS, SIGNALING AND ASTHMA
批准号:
6340711
负责人:
Bruce L. Zuraw
金额:
$12.57万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2001-10-15
中文摘要
通过多种细胞的相互作用,细胞因子,和
英文摘要
Through the interplay of multiple cells, cytokines, and
inflammatory molecules, allergic inflammation can become chronic
and associated with significant morbidity. Kinins are
pluripotent inflammatory mediators that are well recognized to
play an important role in airway inflammation. Bradykinin (BK)
has been shown to be critical for the development of both the
late phase asthmatic response as well as delayed bronchial
hyperresponsiveness following antigen challenge. The role of
des-Arg-BK in airway inflammation has not been elucidated
however recent evidence from our laboratories suggest that it
may also be an important contributor to chronic asthmatic
inflammation. The precise mechanism(s) by which kinins
contribute to airway inflammation remains to be fully
elucidated.
We recently demonstrated that BK, acting through B2 BK
receptors, potently activates the transcription factor NF-kB
thereby stimulating cytokine synthesis. We have now
demonstrated that BK also activates NF-kB in epithelial cells.
Additionally, we have shown that des-Arg-BK, acting through B1
BK receptors, activates the transcription factor AP-1, and that
BK can upregulate B1 BK receptors. The major hypothesis of this
proposal is that kinins promote the development of chronic
airway inflammation through their ability to activate
transcription factors in airway cells leading to: increased
synthesis of cytokines, chemokines and adhesion molecules; and
facilitating the recruitment of additional inflammatory effector
cells. These transcriptional effects of kinins, rather than
their classic effects on smooth muscle tone and vascular
permeability, may thus help provide the critical signals,
bridging the progression of acute allergic reactions into
chronic airway inflammation.
We propose to 1) assess the role of BK in mediating airway
epithelial cell synthesis of cytokines both in vitro and in
vivo, utilizing both transformed and primary human airway
epithelial cells as well as in vivo nasal challenges; and 2)
analyze the molecular mechanisms regulating expression and
functional coupling of B1 BK receptor expression in airway
fibroblasts and epithelial cells, including analyzing the G
protein-associated signaling pathways utilized by B1 BK
receptors in human airway cells. This Project will have
multiple interactions with the other Projects in the Program,
including: sharing of a murine model of in vivo airway
inflammation (Project 3); analysis of B1 BK receptor expression
in T cell subsets (Project 1); assessment of kinin-mediated
phosphorylation of actin-binding proteins (Project 2); and use
of the FACS (FACS Core) and biostatistician (Administrative
Core).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10412915
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10516092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
-
批准号:10044412
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:7929357
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:8196318
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
Dual role of the bradykinin B2 receptor during inflammation
-
批准号:8391112
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:8166834
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2009
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:7950979
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2008
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBI
-
批准号:7724937
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHARMACOKINETICS OF C1INH-NF IN HEREDITARY ANGIOEDEMA SUBJECTS
-
批准号:7724962
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
CLINICAL TRIAL: PHASE II STUDY OF THE SAFETY & EFFICACY OF RECOMBINANT HUMAN C1
-
批准号:7724969
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2007
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8330064
-
项目类别:
-
资助金额:$36.83万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
INVESTIGATE THE EFFICACY & SAFETY OF PURIFIED C1 ESTERASE INHIBITOR FOR HAE
-
批准号:7606584
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8711195
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8897958
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Mechanisms and control of epithelial to mesenchymal transition in chronic asthma
-
批准号:7150800
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8516971
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
Epithelial GILZ in Inflammation and Remodeling
-
批准号:8381195
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2006
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:6922726
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
GILZ Controls TLR-Induced NF-kB Activity In Acute Asthma
-
批准号:7086290
-
项目类别:
-
资助金额:$47.14万
-
财政年份:2005
-
负责人:Bruce L. Zuraw
-
依托单位:
海外基金